Next 10 |
home / stock / dell / dell articles
Shares of Bolt Biotherapeutics, Inc. (NASDAQ:BOLT) fell sharply during Wednesday's session after the company reported first-quarter financial ...
Dell Technologies (NASDAQ:DELL) shares are trading higher on Wednesday following positive analyst coverage from Morgan Stanley. What Happened: Morg...
U.S. stocks were higher, with the Dow Jones gaining around 150 points on Wednesday. Shares of Nextracker Inc. (NASDAQ:NXT) rose sharply during Wedn...
Dell Technologies (NYSE: DELL) ended the recent trading session at $131.68, demonstrating a +0.05% swing from the preceding day's closing price...
On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended buying Dell Technologies Inc. (NYSE:DELL). “That’s a goo...
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many d...
Microsoft Corp (NASDAQ:MSFT), Alphabet Inc (NASDAQ:GOOG) (NASDAQ:GOOGL), and Meta Platforms Inc (NASDAQ:META) have each made significant strides in...
Chinese entities have managed to acquire high-end NVIDIA Corp (NASDAQ:NVDA) chips, despite the U.S. imposing a ban on such technology. The chips we...
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...
News, Short Squeeze, Breakout and More Instantly...
Dell Technologies Inc. Class C Company Name:
DELL Stock Symbol:
NYSE Market:
2024-05-17 18:11:26 ET Shares of Dell Technologies (NYSE: DELL) were moving higher this week, primarily on reports that Dell had won a substantial percentage of contracts relating to Tesla 's AI server buildout. Additionally, AI stocks were up broadly this week after Alpha...
2024-05-17 08:36:00 ET With a valuation more than 6 times sales, Tesla (NASDAQ: TSLA) costs significantly more than rival automotive stocks like Ford and General Motors , both of which sell for mere fractions of 1 times sales. Tesla fans defend Tesla's high valuation , a...
Shares of Bolt Biotherapeutics, Inc. (NASDAQ:BOLT) fell sharply during Wednesday's session after the company reported first-quarter financial ...